Plot Twist: 80% of Clinical Trials DO NOT Miss Enrollment Timelines Because of Poor Recruitment
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
Choosing the right technology to engage clinical trial sites is crucial for study success. Two...
It’s a familiar story in clinical research: a referral comes through, the patient looks like a...
ProofPilot’s acquisition of Lokavant is a move that will have a significant, high-value impact on...
Clinical research is complex, and rightfully so. What we do is often uncharted and difficult....
In a recent interview with The Clinical Trial Vanguard, our Chief Strategy Officer, Joseph Kim...
If you missed DPharm 2024, you also missed watching a live matchmaking event with Nichole Gallatti,...
There is nothing more important in clinical research execution than ensuring sites and patients...
Trial feasibility sometimes feels like a progressive game of bait and switch. In other words, early...
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...